Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-206-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010-01-14 to 2010-03-06
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Benzene, mono C10-13-alkyl derivs, distn. residues, sulfonated
- IUPAC Name:
- Benzene, mono C10-13-alkyl derivs, distn. residues, sulfonated
- Details on test material:
- - Name of test material (as cited in study report): Benzene, mono C10-13-alkyl derivs, distn. resiudes, sulfonated
- Substance type: product
- Physical state: dark brown, viscous liquid
- Storage condition of test material: storage at room temperature
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 activated liver homogenate from male Sprague-Dawley rats
- Test concentrations with justification for top dose:
- - 1st experiment: 5, 1.581, 0.5, 0.158 and 0.05 mg/plate with and without metabolic activation
- 2nd experiment: 5, 2.5, 1.25, 0.63, 0.31 and 0.16 mg/plate with metabolic activation, with strain TA 1537 in addition 0.08 mg/plate with metabolic activation; resp. 1, 0.5, 0.25, 0.13 0.06 and 0.03 mg/plate without metabolic activation
- 3rd experiment: 0.86, 0.72, 0.60, 0.50, 0.42, 0.35 and 0.29 mg/plate without metabolic activation , only TA 1535
All concentrations were applied corresponding to the sulphonated material - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: not given
Controlsopen allclose all
- Untreated negative controls:
- yes
- Remarks:
- sterile deionized water
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 50 µg/mL 2-Nitrofluorne with TA 98; 10 µg/mL Sodiumazide with TA 100 and TA 1535; 1.5 µL/mL Cumene hydroperoxide (ca. 80%) with TA 102; 1.5 mg/mL 9-Aminoacridine with TA 1537
- Remarks:
- without metabolic activation
- Untreated negative controls:
- yes
- Remarks:
- sterile deionized water
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 100 µg/mL with all tester strains; additionally 0.5 mg/mL Benz-a-pyrene with TA 98
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3 per concentration
DETERMINATION OF CYTOTOXICITY
- Method: growth of micro-colonies in the background in comparison to the negative control by estimating the diameter and number of the micro-colonies under the microscope
OTHER EXAMINATIONS:
- Counting of revertants: with a semi-automatic colony counter (Ernst Schütt, jun., Göttingen, Germany)
- Titre of bacteria in the overnight culture: determined by counting colonies formed upon plating an aliquot of a 10E6-fold dilution with NaCl-solution and confirming the concentration by correlating the turbidity of the culture measured photometrically
OTHER:
- Qualitiy assurance of the Salmonella strains: Every half year the bacteria were checked concerning their genotype (sensitivity to crystal violet, sensitivity to ultraviolet light, testing for ampicillin resistance). - Evaluation criteria:
- Criteria for validity of the test:
- the titre of the bacterial culture is sufficient (about 10E9 bacteria/mL)
- the positive control reach at least a doubling of the revertants in comparison to the negative controls
- the numbers of revertants in the negative controls are within the historical ranges (according to Venitt et al. (1984) and laboratory specific historical min-max data)
Criteria for a positive result:
A sample is judged to be mutagenic
- if there is a concentration-related increase over the range tested
- if there is a reproducible increase at one or more concentrations in the number of revertant colonies per plate in at least one strain with or without metabolic activation
- if a statistically significant difference between the mean values can be demonstrated in the case of a reproducible increase of the number of revertants
- if at least a doubling of revertant colonies with the sample compared to the control can be observed (Induction rate (IR) >= 2). - Statistics:
- Calculation of the mean value and standard deviation of the replicates (Microsoft Excel), t-test with Bonferri adjustment and Wilcoxon rang sum test.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- for details see tables below
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium, other: TA 1535, TA 1537, TA 98, TA100 and TA 102
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- exception: cytotoxicity observed at the highest concentration with TA 98 only in the first experiment
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- In the first experiment with the stain TA 1535 a maximum induction rate of 2.1 was obtained with 0.5 mg/plate. In the second experiment, which was performed independently, this result was confirmed. All other concentrations tested were inconspicuous. In both studies this increase was not statistically significant and the increase did not follow any dose-response curve. To confirm this ambiguous result a third test with a very narrow concentration range was performed. In this experiment no increase of revertant colonies at all could be observed.
In the experiment without metabolic acitvation the test item was toxic for the bacteria at higher concentrations. Strain TA 102 turned out to be most sensitive for cytotoxicity. Here up to 250 µg/plate the test item was toxic.
The numbers of the revertants in the negative controls were within the historical ranges. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1: Mean values of the number of revertants and the induction factors obtained in the 1st experiment | ||||||||||||||||
Concentration | S9 mix | TA 98 | TA 100 | TA 102 | TA 1535 | TA 1537 | ||||||||||
mean | RSD [%] |
IR | mean | RSD [%] |
IR | mean | RSD [%] |
IR | mean | RSD [%] |
IR | mean | RSD {%] |
IR | ||
Negative control | - | 20 | 26.5 | - | 77 | 8.3 | - | 206 | 12 | - | 15 | 19.9 | - | 7 | 24.2 | - |
Solvent control | - | 21 | 10.4 | - | 82 | 13.7 | - | 194 | 6.7 | - | 10 | 29.2 | - | 6 | 37 | - |
Positive control | - | 159 | 7.3 | 7.7 | 347 | 7.4 | 4.2 | 1071 | 4.6 | 5.5 | 180 | 31.1 | 18.0 | 289 | 2 | 105.2 |
5 mg/plate | - | 3 * | 57.3 | 0.1 | 44 * | 8.2 | 0.5 | 6 * | 115.5 | 0 | 3 | 21.7 | 0.3 | 2 * | 0 | 0.4 |
1.581 mg/plate | - | 11 * | 20.4 | 0.5 | 64 | 0.9 | 0.8 | 67 * | 39.6 | 0.3 | 9 | 34.4 | 0.9 | 3 | 0 | 0.5 |
0.5 mg/plate | - | 15 | 10 | 0.7 | 75 | 4.7 | 0.9 | 123 * | 12 | 0.6 | 21 | 45.9 | 2.1 | 7 | 14.3 | 1.3 |
0.158 mg/plate | - | 23 | 2.5 | 1.1 | 76 | 6.2 | 0.9 | 134 (*) | 11.9 | 0.7 | 11 | 27 | 1.1 | 6 | 27 | 1.0 |
0.05 mg/plate | - | 24 | 15 | 1.2 | 71 | 1.6 | 0.9 | 143 | 15.8 | 0.7 | 12 | 8.3 | 1.2 | 7 | 37.7 | 1.2 |
Negative control | + | 23 | 15.4 | - | 92 | 8.3 | - | 223 | 6.2 | - | 11 | 19.3 | - | 6 | 20.4 | - |
Solvent control | + | 21 | 27 | - | 84 | 13.4 | - | 188 | 16.3 | - | 13 | 19.9 | - | 7 | 39.8 | - |
Positive control (2-AA) | + | 605 | 16.6 | 28.3 | 864 | 0.7 | 10.3 | 427 | 2.6 | 2.3 | 177 | 27.2 | 14.0 | 589 | 2 | 81.9 |
Positive control (B-a-P) | + | 223 | 25.5 | 10.4 | ||||||||||||
5 mg/plate | + | 17 (*) | 15.6 | 0.8 | 54 | 12 | 0.6 | 235 | 5.6 | 1.3 | 8 | 32.8 | 0.6 | 2 | 65.5 | 0.3 |
1.581 mg/plate | + | 23 | 22.6 | 1.1 | 86 | 8.7 | 1.0 | 336 | 7.6 | 1.8 | 9 | 13.3 | 0.7 | 5 | 43.3 | 0.7 |
0.5 mg/plate | + | 23 | 17.3 | 1.1 | 79 | 10.6 | 0.9 | 338 | 7.5 | 1.8 | 11 | 47.2 | 0.8 | 6 | 48.2 | 0.9 |
0.158 mg/plate | + | 26 | 9.6 | 1.2 | 76 | 12.2 | 0.9 | 203 | 3.1 | 1.6 | 9 | 11.1 | 0.7 | 10 | 6 | 1.3 |
0.05 mg/plate | + | 27 | 22.1 | 1.3 | 83 | 8.5 | 1.0 | 248 | 7.4 | 1.3 | 12 | 33.8 | 1.0 | 11 | 21.7 | 1.5 |
RSD = relative standard deviation IR = Induction Rate * = cytotoxic effects (background growth) | ||||||||||||||||
Table 2: Mean values of the number of revertants and the induction factors obtained in the 2nd experiment | ||||||||||||||||
Concentration | S9 mix | TA 98 | TA 100 | TA 102 | TA 1535 | TA 1537 | ||||||||||
mean | RSD [%] |
IR | mean | RSD [%] |
IR | mean | RSD [%] |
IR | mean | RSD [%] |
IR | mean | RSD {%] |
IR | ||
Negative control | - | 25 | 20.4 | - | 102 | 14.3 | - | 261 | 4.2 | - | 13 | 37.2 | - | 7 | 24.2 | - |
Solvent control | - | 35 | 15.5 | - | 76 | 8.5 | - | 175 | 25.3 | - | 8 | 31.9 | - | 8 | 48 | - |
Positive control | - | 166 | 11.3 | 4.8 | 174 | 3.7 | 2.3 | 521 | 6.0 | 3.0 | 104 | 16.7 | 13.0 | 638 | 44.7 | 83.9 |
1 mg/plate | - | 10 (*) | 15.8 | 0.3 | 46 (*) | 32.3 | 0.6 | 49 (*) | 47.6 | 0.3 | 9 | 75.1 | 1.1 | 5 | 24.7 | 0.6 |
0.5 mg/plate | - | 13 (*) | 23.1 | 0.4 | 68 | 9.7 | 0.9 | 63 (*) | 14.5 | 0.4 | 17 | 10.2 | 2.1 | 4 | 86.6 | 0.5 |
0.25 mg/plate | - | 14 | 33 | 0.4 | 64 | 11.1 | 0.8 | 126 (*) | 22.5 | 0.7 | 7 | 47.9 | 0.9 | 11 | 42.3 | 1.4 |
0.13 mg/plate | - | 23 | 22.2 | 0.6 | 61 | 9.1 | 0.8 | 120 | 2.9 | 0.7 | 8 | 6.9 | 1.0 | 7 | 34.3 | 1.0 |
0.06 mg/plate | - | 22 | 15.7 | 0.6 | 65 | 12.3 | 0.9 | 142 | 12 | 0.8 | 8 | 6.89 | 1.0 | 12 | 22 | 1.6 |
0.03 mg/plate | - | 26 | 9.8 | 0.7 | 71 | 11.4 | 0.9 | 171 | 3.2 | 1.0 | 11 | 10.8 | 1.3 | 13 | 7.7 | 1.7 |
Negative control | + | 27 | 20 | - | 74 | 4.1 | - | 272 | 4.3 | - | 10 | 24 | - | 8 | 15 | - |
Solvent control | + | 22 | 16 | - | 72 | 9.5 | - | 224 | 15 | - | 10 | 11 | - | 10 | 39.4 | - |
Positive control (2-AA) | + | 127 | 77.1 | 5.7 | 628 | 7.1 | 8.7 | 483 | 2.5 | 2.2 | 118 | 4.7 | 11.3 | 228 | 12.7 | 23.8 |
Positive control (B-a-P) | + | 625 | 1.3 | 27.5 | ||||||||||||
5 mg/plate | + | 16 | 22.5 | 0.7 | 46 | 7 | 0.6 | 164 | 18.1 | 0.7 | 8 | 74.2 | 0.7 | 4 | 31.5 | 0.4 |
2.5 mg/plate | + | 34 | 28.1 | 1.5 | 53 | 5.4 | 0.7 | 307 | 8.3 | 1.4 | 7 | 15.7 | 0.7 | 6 | 0 | 0.6 |
1.25 mg/plate | + | 25 | 14.4 | 1.1 | 61 | 12.7 | 0.8 | 318 | 6.9 | 1.4 | 8 | 50 | 0.8 | 5 | 20 | 0.5 |
0.63 mg/plate | + | 26 | 17.6 | 1.2 | 75 | 21.4 | 1.0 | 290 | 3.8 | 1.3 | 7 | 7.9 | 0.7 | 9 | 11.1 | 0.9 |
0.31 mg/plate | + | 27 | 15.2 | 1.2 | 67 | 2.3 | 0.9 | 296 | 3.3 | 1.3 | 8 | 15.1 | 0.7 | 9 | 34.4 | 1.0 |
0.16 mg/plate | + | 36 | 26 | 1.6 | 70 | 5.2 | 1.0 | 301 | 3 | 1.3 | 8 | 37.5 | 0.8 | 8 | 12.5 | 0.8 |
0.08 mg/plate | + | 12 | 17.8 | 1.2 | ||||||||||||
RSD = relative standard deviation IR = Induction Rate * = cytotoxic effects (background growth) | ||||||||||||||||
Table 3: Mean values of the number of revertants and the induction factors obtained in the 3rd experiment | ||||||||||||||||
Concentration | S9 mix | TA 1535 | ||||||||||||||
mean | RSD | IR | ||||||||||||||
Negative control | - | 12 | 38.9 | - | ||||||||||||
Solvent control | - | 12 | 31.2 | - | ||||||||||||
Positive control | - | 182 | 7.6 | 15.2 | ||||||||||||
0.86 mg/plate | - | 9 | 41.6 | 0.7 | ||||||||||||
0.72 mg/plate | - | 8 | 42.2 | 0.6 | ||||||||||||
0.60 mg/plate | - | 8 | 36.7 | 0.7 | ||||||||||||
0.50 mg/plate | - | 10 | 19.9 | 0.9 | ||||||||||||
0.42 mg/plate | - | 10 | 33 | 0.9 | ||||||||||||
0.35 mg/plate | - | 10 | 14.5 | 0.9 | ||||||||||||
0.29 mg/plate | - | 11 | 13.7 | 0.9 | ||||||||||||
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
According to the results achieved the test item Benzene, mono C10-13-alkyl derivs, distn. residues, sulfonated was evaluated as not mutagneic under the test conditions applied up to a test concentration of 5 mg per plate (related to the sulfonated material of 73.2%). - Executive summary:
This Bacterial Reverse Mutation Test (Ames test) with S. typhimurium strains TA 98, TA 100, TA 102 , TA 1535 and TA 1537 was carried out according to OECD Guideline 471 (July 1997).
The test item Benzene, mono C10 -13 -alkyl derivs, distn. residues, sulfonated was evaluated as not mutagenic under the test conditions applied up to a test concentration of 5 mg per plate (related to the sulfonated material of 73.2%) which is the highest test concentration required according to the guideline.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.